Zobrazeno 1 - 10
of 92
pro vyhledávání: '"D. Mintzer"'
Autor:
D. Mintzer, Malcolm Maclure, J.B. Sherwood, G. H. Tofler, Murray A. Mittleman, James E. Muller
Publikováno v:
Journal of the American College of Cardiology. 31
Publikováno v:
Journal of Clinical Oncology. 27:e11577-e11577
e11577 Background: The addition of trastuzumab to adjuvant chemotherapy is standard for Her2(+) breast cancer. In our practice, adjuvant docetaxel/cyclophosphamide (DC) + 1 yr of trastuzumab is offered to pts with low-risk Her2(+) disease. Although t
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
The Psychoanalytic Study of the Child. 39:561-589
(1984). Parenting an Infant with a Birth Defect. The Psychoanalytic Study of the Child: Vol. 39, No. 1, pp. 561-589.
Publikováno v:
Journal of Applied Physics. 33:2710-2714
When a series of uniform acoustic pulses is transmitted through a medium whose refractive index varies in a random manner, the received pulses vary randomly about an average amplitude. A theory developed by Mintzer [J. Acoust. Soc. Am. 25, 922 (1953)
Autor:
D. Mintzer, E. T. Kornhauser
Publikováno v:
The Journal of the Acoustical Society of America. 25:903-906
The conventional treatment of a vibrating membrane with a small mass load, originated by Rayleigh, leads to perturbed eigenfrequencies slightly lower than the unperturbed values and independent of the area of the load so long as it is small compared
Autor:
R. G. Stone, D. Mintzer
Publikováno v:
The Journal of the Acoustical Society of America. 38:843-846
Further experiments have been made relating the acoustic fluctuations, resulting from transmission through water whose refractive index varies randomly in space and time, to the range from source to receiver, the acoustic frequency, and the parameter
Publikováno v:
Journal of biological response modifiers. 7(3)
Interferon has been reported to have activity in the treatment of multiple myeloma. We studied 24 myeloma patients treated with human lymphoblastoid interferon (Wellferon) by intramuscular injection twice weekly at an initial dose of 3 MU/M2 (three p
Autor:
S E, Krown, D, Mintzer, S, Cunningham-Rundles, D, Niedzwiecki, M, Krim, A I, Einzig, J L, Gabrilove, B, Shurgot, J, Gessula
Publikováno v:
Cancer treatment reports. 71(1)
A total of 22 patients with advanced measurable colorectal carcinoma were treated with human lymphoblastoid interferon, 15 X 10(6) U/m2 im 3 times a week, in a trial designed to evaluate therapeutic activity, toxic effects, and biological response mo
Autor:
D. Mintzer, J. L. Davis
Publikováno v:
Journal of Applied Mechanics. 56:733-734